Federal Register / Vol. 74, No. 157 / Monday, August 17, 2009 / Notices 41447 

Control and Prevention, announces the 

following meeting for the 

aforementioned subcommittee: 

Time and Date: 10 a.m.–5 p.m., September 

3, 2009. 

Place: Cincinnati Airport Marriott, 2395 

Progress Drive, Hebron, Kentucky 41018. 

Telephone (859) 334–4611, Fax (859) 334– 

4619. 

Status: Open to the public, but without a 

public comment period. To access by 

conference call dial the following 

information 1(866) 659–0537, Participant 

Pass Code 9933701. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation Program 

Act of 2000 to advise the President on a 

variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that have 

been promulgated by the Department of 

Health and Human Services (HHS) as a final 

rule; advice on methods of dose 

reconstruction which have also been 

promulgated by HHS as a final rule; advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort (SEC). 

In December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, which 

subsequently delegated this authority to CDC. 

NIOSH implements this responsibility for 

CDC. The charter was issued on August 3, 

2001, renewed at appropriate intervals, and 

will expire on August 3, 2011. 

Purpose: The Advisory Board is charged 

with (a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. The Subcommittee for Dose 

Reconstruction Reviews was established to 

aid the Advisory Board in carrying out its 

duty to advise the Secretary, HHS, on dose 

reconstruction. 

Matters To Be Discussed: The agenda for 

the Subcommittee meeting includes: 

Discussion of dose reconstruction cases 

under review; OCAS dose reconstruction 

quality management and assurance activities; 

selection of an additional set of cases for 

review. 

In the event an individual cannot attend, 

written comments may be submitted. Any 

written comments received will be provided 

at the meeting and should be submitted to 

the contact person below well in advance of 

the meeting. 

For More Information Contact: Theodore 

Katz, Executive Secretary, NIOSH, CDC, 1600 

Clifton Road, Mailstop E–20, Atlanta GA 

30333, Telephone (513) 533–6800, Toll Free 

1(800) CDC–INFO, E-mail ocas@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: August 10, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–19701 Filed 8–14–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director, 

Centers for Disease Control and 

Prevention (ACD, CDC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following Meeting of the 

aforementioned committee: 

Time and Date: 4:30 p.m.–6 p.m., 

September 1, 2009. 

Place: The teleconference call will 

originate at the Centers for Disease Control 

and Prevention in Atlanta, Georgia. Please 

see Supplementary Information for details on 

accessing the teleconference. 

Status: Open to the public, teleconference 

access limited only by availability of 

telephone ports. 

Purpose: The committee will provide 

advice to the CDC Director on strategic and 

other broad issues facing CDC. 

Matters To Be Discussed: The committee 

will discuss and decide on recommendations 

from its Ethics Subcommittee, National 

Biosurveillance Advisory Subcommittee, and 

the Health Disparities Subcommittee. The 

Ethics Subcommittee will make 

recommendations on using travel restrictions 

for individuals with infectious illnesses; and 

discuss a draft charge that clearly articulates 

the ethical foundation for focusing on health 

protection activities and examining the social 

determinants of health. The National 

Biosurveillance Advisory Subcommittee will 

present their final report on biosurveillance 

recommendations. The Health Disparities 

Subcommittee will present their mission. 

The ACD, CDC will also receive an update on 

H1N1 and the plans for the upcoming flu 

season. 

Agenda items are subject to change as 

priorities dictate. 

Supplementary Information: This 

conference call is scheduled to begin at 4:30 

p.m. To participate in the teleconference, 

please dial 1–800–593–9961 and enter 

conference code 3699611. You will then be 

automatically connected to the call. 

Contact Person for More Information: Anne 

Haddix, M.D., Designated Federal Officer, 

Advisory Committee to the Director, CDC, 

1600 Clifton Road, NE., M/S D–14, Atlanta, 

Georgia 30333. Telephone 404–639–0663. 

The Director, Management Analysis and 

Services office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: August 10, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. E9–19698 Filed 8–14–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center on Minority Health and 

Health Disparities; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Council on Minority 

Health and Health Disparities. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council on Minority Health and Health 

Disparities; NACMHD 

Date: September 8, 2009 

Closed: 8 a.m. to 10 a.m. 

mstockstill on DSKH9S0YB1PROD with NOTICES

41448 Federal Register / Vol. 74, No. 157 / Monday, August 17, 2009 / Notices 

Agenda: To review and evaluate grant 

applications and/or proposals 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817 

Open: 10:00 a.m. to 5:00 p.m. 

Agenda: The agenda will include opening 

remarks, administrative matters, Director’s 

Report, NCMHD Health Disparities update, 

Scientific Programs Highlight, and other 

business of the Council. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817 

Contact Person: Donna Brooks, Asst. 

Director for Administration, National Center 

on Minority Health and Health Disparities, 

National Institutes of Health, 6707 

Democracy Blvd., Suite 800, Bethesda, MD 

20892, 301–435–2135, brooksd@

ncmhd.nih.gov. 

This meeting is being published less than 

15 days prior to the meeting due to the 

timing limitations imposed by the review and 

funding cycle. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

Dated: August 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–19690 Filed 8–14–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB September Meeting 1. 

Date: September 8–11, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892. (Virtual 

Meeting). 

Contact Person: Mohan Viswanathan, PhD, 

Scientific Review Officer, National Center for 

Research Resources, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Blvd., Room 1084, Bethesda, MD 

20892–4874. 301–435–0829. mv10f@nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB September Meeting 2. 

Date: September 8–11, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Mohan Viswanathan, PhD, 

Scientific Review Officer, National Center for 

Research Resources, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Blvd., Room 1084, Bethesda, MD 

20892–4874. 301–435–0829. Mv10f@nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB September Meeting 3. 

Date: September 8–11, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Carol Lambert, PhD, 

Scientific Review Officer, Office of Review, 

National Institutes of Health, NCRR, 6701 

Democracy Blvd., 1 Democracy Plaza, Room 

1076, MSC 4874, Bethesda, MD 20892. (301) 

435–0814. lambert@mail.nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB September Meeting 4. 

Date: September 8–11, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Carol Lambert, PhD, 

Scientific Review Officer, Office of Review, 

National Institutes of Health, NCRR, 6701 

Democracy Blvd., 1 Democracy Plaza, Room 

1076, MSC 4874, Bethesda, MD 20892. (301) 

435–0814. lambert@mail.nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Comparative Medicine SEP. 

Date: September 22, 2009. 

Time: 12 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Lisa A Newman, SCD, 

Scientific Review Officer, National Institutes 

of Health, National Center for Research 

Resources, Office of Review, Room 1074, 

6701 Democracry Blvd. MSC 4874, Bethesda, 

MD 20892. 301–435–0965. 

newmanla2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333; 93.702, ARRA Related 

Construction Awards., National Institutes of 

Health, HHS) 

Dated: August 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–19689 Filed 8–14–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; ‘‘Bacterial Immunity’’. 

Date: September 8, 2009. 

Time: 12:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817 (Telephone Conference 

Call) 

Contact Person: Annie Walker-Abbey, PhD, 

Scientific Review Officer, Scientific Review 

Program, NIAID/NIH/DHHS, 6700B 

Rockledge Drive, RM 3266, MSC–7616, 

Bethesda, MD 20892–7616, 301–451–2671, 

aabbey@niaid.nih.gov. 

mstockstill on DSKH9S0YB1PROD with NOTICES